Carol J. Lam

407 total citations
10 papers, 324 citations indexed

About

Carol J. Lam is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Carol J. Lam has authored 10 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Genetics. Recurrent topics in Carol J. Lam's work include Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (8 papers) and Diabetes Management and Research (6 papers). Carol J. Lam is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes and associated disorders (8 papers) and Diabetes Management and Research (6 papers). Carol J. Lam collaborates with scholars based in United States. Carol J. Lam's co-authors include Jake A. Kushner, Aaron R. Cox, Matthew M. Rankin, Daniel R. Jacobson, Thomas J. Van Winkle, Emily Shields, Rebecka S. Hess, Ornella Barrandon, Changhong Li and Erica P. Cai and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Carol J. Lam

10 papers receiving 321 citations

Peers

Carol J. Lam
Yarong Lu Canada
Aarti Surti United States
Giorgio Basile United States
Qidi Wang China
John Buchlis United States
Christine Proença United Kingdom
Elisa De Franco United Kingdom
Munish Mehta Australia
Yarong Lu Canada
Carol J. Lam
Citations per year, relative to Carol J. Lam Carol J. Lam (= 1×) peers Yarong Lu

Countries citing papers authored by Carol J. Lam

Since Specialization
Citations

This map shows the geographic impact of Carol J. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol J. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol J. Lam more than expected).

Fields of papers citing papers by Carol J. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol J. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol J. Lam. The network helps show where Carol J. Lam may publish in the future.

Co-authorship network of co-authors of Carol J. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Carol J. Lam. A scholar is included among the top collaborators of Carol J. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol J. Lam. Carol J. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ahn, Surl-Hee, Anne Granger, Matthew M. Rankin, et al.. (2019). Tamoxifen suppresses pancreatic β-cell proliferation in mice. PLoS ONE. 14(9). e0214829–e0214829. 20 indexed citations
2.
Lam, Carol J., et al.. (2019). Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age. Diabetes. 68(5). 963–974. 10 indexed citations
3.
Lam, Carol J., et al.. (2018). Low-Level Insulin Content Within Abundant Non-β Islet Endocrine Cells in Long-standing Type 1 Diabetes. Diabetes. 68(3). 598–608. 32 indexed citations
4.
Lam, Carol J., Aaron R. Cox, Daniel R. Jacobson, Matthew M. Rankin, & Jake A. Kushner. (2018). Highly Proliferative α-Cell–Related Islet Endocrine Cells in Human Pancreata. Diabetes. 67(4). 674–686. 38 indexed citations
5.
Lam, Carol J., Daniel R. Jacobson, Matthew M. Rankin, Aaron R. Cox, & Jake A. Kushner. (2017). β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis. The Journal of Clinical Endocrinology & Metabolism. 102(8). 2647–2659. 50 indexed citations
6.
Cox, Aaron R., et al.. (2017). Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice. Endocrinology. 158(6). 1701–1714. 16 indexed citations
7.
Cox, Aaron R., Ornella Barrandon, Erica P. Cai, et al.. (2016). Resolving Discrepant Findings on ANGPTL8 in β-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy. PLoS ONE. 11(7). e0159276–e0159276. 35 indexed citations
8.
Cox, Aaron R., Carol J. Lam, Matthew M. Rankin, et al.. (2016). Extreme obesity induces massive beta cell expansion in mice through self-renewal and does not alter the beta cell lineage. Diabetologia. 59(6). 1231–1241. 25 indexed citations
9.
Shields, Emily, Carol J. Lam, Aaron R. Cox, et al.. (2015). Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS ONE. 10(6). e0129809–e0129809. 39 indexed citations
10.
Cox, Aaron R., et al.. (2015). Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice. Diabetologia. 58(7). 1523–1531. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026